Table 6.
Identified significant gene ontologies associated with the comorbidities.
| Database | GO ID | Gene ontology | P value | Genes in the ontology | Associated comorbidity |
|---|---|---|---|---|---|
| GO biological process | GO: 0006954 | Inflammatory response | 3.18E − 06 | SERPINA3; CXCL10; CXCL9; CXCL8; ADORA2A; CCL20; IL1B; ABCF1 | Hypertension |
| GO biological process | GO: 0032496 | Response to lipopolysaccharide | 2.89E − 06 | CXCL10; CXCL9; CXCL8; IL1B; SERPINE1; ANKRD1; S100A7 | Hypertension |
| GO biological process | GO: 0019221 | Cytokine-mediated signaling pathway | 1.04E − 04 | CXCL8; IFI27; IL23A; HLA-B; HLA-DRA; TRIM26; LMNB1; PSMB9 | Diabetes |
| GO biological process | GO: 0043312 | Neutrophil degranulation | 2.80E − 02 | HLA-B; MCEMP1; MMP8; OSCAR | Diabetes |
| GO biological process | GO: 0002283 | Neutrophil activation involved in immune response | 2.87E − 02 | HLA-B; MCEMP1; MMP8; OSCAR | Diabetes |
| GO biological process | GO: 0030198 | Extracellular matrix organization | 3.59E − 04 | MMP7; ITGB2; LCP1; MMP8; NPNT; MMP9 | Obesity |
| GO biological process | GO: 0043062 | Extracellular structure organization | 5.93E − 04 | MMP7; ITGB2; MMP8; NPNT; MMP9 | Obesity |
| GO cellular component | GO: 0005887 | Integral component of plasma membrane | 8.31E − 03 | KIRREL3; CHRNA1; VIPR1; KIRREL2; GCGR; SEMA3G; SLC1A3; PTPRH; MERTK; AGER; SLC8A2; AQP1; TGFBR3; CDH2; P2RY1; SYNDIG1; CD36; RHCG; IL6R | Lung cancer |
| GO cellular component | GO: 0062023 | Collagen-containing extracellular matrix | 3.82E − 06 | VWF; ATRNL1; COL11A2; BGN; NPNT; L1CAM; SOD3; MFAP4; CDH2; COL5A3; SMOC1; ANGPTL2; HMCN1 | Lung cancer |
| GO biological process | GO: 0050808 | Synapse organization | 3.65E − 06 | KIRREL3; CHRNA1; CDH2; DSCAM; SPOCK2; L1CAM; SHANK3; SLC8A2 | Lung cancer |